CTOR · Citius Oncology, Inc.

Summary

Citius Oncology, Inc. issued a press release on March 10, 2026, announcing positive topline results from a completed investigator-initiated Phase 1 clinical trial. The filing includes Exhibit 99.1, the press release, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

Key takeaways

• Issued press release dated March 10, 2026
• Announced positive topline results
• Completed investigator-initiated Phase 1 clinical trial
• Exhibit 99.1: Press release
• Form 8-K filed on 2026-03-10